Crescita Therapeutics Inc. (TSX: CTX)
Canada
· Delayed Price · Currency is CAD 0.640
+0.010 (1.59%)
Aug 22, 2024, 1:48 PM EDT
Crescita Therapeutics Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
| Revenue | 16.84 | 17.52 | 23.53 | 16.77 | 15.64 | 22.34 | Upgrade
|
| Revenue Growth (YoY) | -22.84% | -25.52% | 40.29% | 7.22% | -29.98% | 34.33% | Upgrade
|
| Cost of Revenue | 7.64 | 7.16 | 10.34 | 6.76 | 4.37 | 5.8 | Upgrade
|
| Gross Profit | 9.21 | 10.36 | 13.18 | 10.01 | 11.27 | 16.54 | Upgrade
|
| Selling, General & Admin | 10.34 | 10.12 | 10.57 | 9.5 | 7.85 | 8.46 | Upgrade
|
| Research & Development | 0.69 | 0.7 | 0.61 | 0.63 | 1.1 | 1.38 | Upgrade
|
| Operating Expenses | 12.47 | 12.32 | 12.65 | 11.51 | 10.44 | 11.57 | Upgrade
|
| Operating Income | -3.27 | -1.96 | 0.53 | -1.5 | 0.83 | 4.97 | Upgrade
|
| Interest Expense | -0.08 | -0.09 | -0.16 | -0.24 | -0.25 | -0.68 | Upgrade
|
| Interest & Investment Income | 0.52 | 0.51 | 0.26 | 0.18 | 0.29 | 0.28 | Upgrade
|
| Earnings From Equity Investments | -0.01 | 0.02 | -0.06 | 0.01 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.05 | 0.01 | -0.05 | -0.24 | 0.18 | -0.11 | Upgrade
|
| EBT Excluding Unusual Items | -2.79 | -1.51 | 0.52 | -1.79 | 1.05 | 4.45 | Upgrade
|
| Asset Writedown | - | - | - | - | -1.92 | - | Upgrade
|
| Other Unusual Items | - | -0.02 | -0.12 | 0.78 | 1.39 | -1.27 | Upgrade
|
| Pretax Income | -2.79 | -1.53 | 0.4 | -1.01 | 0.52 | 3.18 | Upgrade
|
| Income Tax Expense | 0.2 | 0.46 | -0.46 | 0.1 | 0.48 | 1.33 | Upgrade
|
| Earnings From Continuing Operations | -2.98 | -1.99 | 0.86 | -1.11 | 0.04 | 1.86 | Upgrade
|
| Net Income | -2.98 | -1.99 | 0.86 | -1.11 | 0.04 | 1.86 | Upgrade
|
| Net Income to Common | -2.98 | -1.99 | 0.86 | -1.11 | 0.04 | 1.86 | Upgrade
|
| Net Income Growth | - | - | - | - | -98.01% | -22.58% | Upgrade
|
| Shares Outstanding (Basic) | 20 | 20 | 21 | 21 | 21 | 21 | Upgrade
|
| Shares Outstanding (Diluted) | 20 | 20 | 21 | 21 | 21 | 22 | Upgrade
|
| Shares Change (YoY) | -4.26% | -3.55% | 1.18% | -1.02% | -6.79% | 14.16% | Upgrade
|
| EPS (Basic) | -0.15 | -0.10 | 0.04 | -0.05 | 0.00 | 0.09 | Upgrade
|
| EPS (Diluted) | -0.15 | -0.10 | 0.04 | -0.05 | 0.00 | 0.09 | Upgrade
|
| EPS Growth | - | - | - | - | -97.96% | -27.92% | Upgrade
|
| Free Cash Flow | -0.26 | 1.94 | -1.25 | -1.94 | 5.55 | 5.09 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | 0.10 | -0.06 | -0.09 | 0.26 | 0.23 | Upgrade
|
| Gross Margin | 54.66% | 59.15% | 56.03% | 59.72% | 72.08% | 74.03% | Upgrade
|
| Operating Margin | -19.41% | -11.16% | 2.25% | -8.92% | 5.33% | 22.24% | Upgrade
|
| Profit Margin | -17.72% | -11.33% | 3.66% | -6.59% | 0.24% | 8.30% | Upgrade
|
| Free Cash Flow Margin | -1.52% | 11.09% | -5.31% | -11.59% | 35.48% | 22.79% | Upgrade
|
| EBITDA | -2.23 | -0.86 | 1.61 | -0.48 | 2.02 | 6.39 | Upgrade
|
| EBITDA Margin | -13.25% | -4.89% | 6.86% | -2.86% | 12.91% | 28.62% | Upgrade
|
| D&A For EBITDA | 1.04 | 1.1 | 1.08 | 1.02 | 1.19 | 1.43 | Upgrade
|
| EBIT | -3.27 | -1.96 | 0.53 | -1.5 | 0.83 | 4.97 | Upgrade
|
| EBIT Margin | -19.41% | -11.16% | 2.25% | -8.92% | 5.33% | 22.24% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 92.88% | 41.67% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.